Skip to main content
. 2023 Jan 8;15(2):414. doi: 10.3390/cancers15020414

Table 1.

Patient characteristics for all included patients and PSM pairs.

Characteristics All Included Patients PSM Patients
Open VATS p-Value Open VATS p-Value
Age, year ± SD 57.6 ± 9.52 61.33 ± 8.54 0.031 63.09 ± 9.9 62.03 ± 8.03 0.293
Sex, n (%) 0.664 0.695
Male 82 (64.1) 47 (61) 38 (59.3) 36 (56.2)
FEV1%, mean ± SD 90.50 ± 16.64 88.94 ± 16.98 0.008 87.16 ± 12.8 88.35 ± 17.2 0.579
DLCO%, mean ± SD 65.92 ± 13.76 67.34 ± 15.24 0.599 61.7 ± 12.56 68.09 ± 16.43 0.105
Comorbidities, n (%)
Hypertension 28 (21.9) 19 (24.7) 0.739 19 (29.6) 17(26.5) 0.653
Diabetes 17 (13.3) 7 (9.1) 0.041 7 (11) 7 (11) 1
Cardiac disease 21 (16.4) 5 (6.5) 0.039 5 (7.8) 3 (4.6) 0.358
COPD 25 (19.5) 19 (24.7) 0.385 10 (15.6) 12 (18.7) 0.633
Smoking history, n (%) 103 (80.5) 65 (84.4) 0.106 51 (79.7) 54 (84.4) 0.080
cTm size, mm ± SD 54.12 ± 35.77 31.16 ± 17.33 0.002 37.84 ± 20.8 35.01 ± 17.2 0.714
cTNM, n (%) 0.033 0.435
IIIA 77(60.2) 58 (75.3) 43 (67.2) 48 (75)
IIIB 51 (39.8) 19 (24.7) 21(32.8) 16 (25)
Induction therapy, n (%) 128 (100) 77 (100) 1 64 (100) 64 (100) 1
Time from preoperative therapy to surgery (days) 95 (72–135) 91(72–128) 0.723 92 (72–130) 89 (72–126) 0.642
Tumor location, n (%) 0.880 0.983
Right upper 50 (39.1) 32 (41.6) 27 (42.2) 25 (39.1)
Right middle 4 (3.1) 4 (5.2) 3 (4.7) 4 (6.3)
Right lower 21 (16.4) 15 (19.5) 11 (17.2) 10 (15.6)
Left upper 34 (26.6) 17 (22.1) 15 (23.4) 17 (26.5)
Left lower 16 (12.5) 10 (13) 8 (12.5) 8 (12.5)
Surgical procedure
Lobectomy 47 (36.7) 59 (76.6) 24 (37.5) 48 (75)
Bilobectomy 28 (21.9) 10 (13) 13 (20.3) 8 (12.5)
Pneumonectomy 32 (25) 3 (3.9) 16 (25) 3 (4.7)
Sleeve lobectomy 21 (16.4) 5 (6.5) 11 (17.2) 5 (7.8)

VATS: Video-assisted thoracoscopic surgery; SD: standard deviation; FEV1: forced expiratory volume in 1 s; DLCO: diffusing capacity of carbon monoxide; COPD: chronic obstructive pulmonary diseases. p values in bold are statistically significant.